Microbial ecology and adaptation in cystic fibrosis airways

Environmental Microbiology

Volumn 13, Issue 7, 2011, Pages 1682-1689

  Yang, Lei ^a   Jelsbak, Lars ^a   Molin, Søren ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; CYSTIC FIBROSIS; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MUTATION; OPPORTUNISTIC INFECTION; ORGANISMAL INTERACTION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION;

ADAPTATION, PHYSIOLOGICAL; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL INTERACTIONS; MUTATION; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

PSEUDOMONAS AERUGINOSA;

EID: 79959829979     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/j.1462-2920.2011.02459.x     Document Type: Article

References (82)

1. Alvarez-Ortega, C., and Harwood, C.S. (2007) Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65: 153-165.
2. Andersson, D.I., and Hughes, D. (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271.
3. Anthony, M., Rose, B., Pegler, M.B., Elkins, M., Service, H., and Thamotharampillai, K etal. (2002) Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40: 2772-2778.
4. Armstrong, D.S., Grimwood, K., Carlin, J.B., Carzino, R., Olinsky, A., and Phelan, P.D. (1996) Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 21: 267-275.
5. Baltimore, R.S., Christie, C.D., and Smith, G.J. (1989) Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140: 1650-1661.
6. Baughman, R.P., Keeton, D.A., Perez, C., and Wilmott, R.W. (1997) Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med 156: 286-291.
7. Biswas, L., Biswas, R., Schlag, M., Bertram, R., and Gotz, F. (2009) Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol 75: 6910-6912.
8. Bjarnsholt, T., Jensen, P.O., Fiandaca, M.J., Pedersen, J., Hansen, C.R., and Andersen, C.B etal. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44: 547-558.
9. Borriello, G., Werner, E., Roe, F., Kim, A.M., Ehrlich, G.D., and Stewart, P.S. (2004) Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48: 2659-2664.
10. Boucher, R.C. (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58: 157-170.
11. Boulette, M.L., Baynham, P.J., Jorth, P.A., Kukavica-Ibrulj, I., Longoria, A., Barrera, K., etal. (2009) Characterization of alanine catabolism in Pseudomonas aeruginosa and its importance for proliferation in vivo. J Bacteriol 191: 6329-6334.
12. Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., etal. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
13. Canton, R., and del Campo, R. (2010) Cystic fibrosis: deciphering the complexity. Clin Microbiol Infect 16: 793-797.
14. Cerca, N., Jefferson, K.K., Oliveira, R., Pier, G.B., and Azeredo, J. (2006) Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 74: 4849-4855.
15. Chen, F., Xia, Q., and Ju, L.K. (2006) Competition between oxygen and nitrate respirations in continuous culture of Pseudomonas aeruginosa performing aerobic denitrification. Biotechnol Bioeng 93: 1069-1078.
16. Ciofu, O., Riis, B., Pressler, T., Poulsen, H.E., and Hoiby, N. (2005) Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49: 2276-2282.
17. Comolli, J.C., and Donohue, T.J. (2004) Differences in two Pseudomonas aeruginosa cbb3 cytochrome oxidases. Mol Microbiol 51: 1193-1203.
18. Cooper, T.F., Rozen, D.E., and Lenski, R.E. (2003) Parallel changes in gene expression after 20, 000 generations of evolution in Escherichiacoli. Proc Natl Acad Sci USA 100: 1072-1077.
19. Cunningham, L., Pitt, M., and Williams, H.D. (1997) The cioAB genes from Pseudomonas aeruginosa code for a novel cyanide-insensitive terminal oxidase related to the cytochrome bd quinol oxidases. Mol Microbiol 24: 579-591.
20. D'Argenio, D.A., Wu, M., Hoffman, L.R., Kulasekara, H.D., Deziel, E., Smith, E.E., etal. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512-533.
21. Doring, G., and Gulbins, E. (2009) Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 11: 208-216.
22. Duan, K., Dammel, C., Stein, J., Rabin, H., and Surette, M.G. (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50: 1477-1491.
23. Ernst, R.K., D'Argenio, D.A., Ichikawa, J.K., Bangera, M.G., Selgrade, S., Burns, J.L., etal. (2003) Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol 5: 1341-1349.
24. Garrett, E.S., Perlegas, D., and Wozniak, D.J. (1999) Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J Bacteriol 181: 7401-7404.
25. Hall-Stoodley, L., Costerton, J.W., and Stoodley, P. (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2: 95-108.
26. Hancock, R.E., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P., and Pier, G.B. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170-177.
27. Harris, J.K., De Groote, M.A., Sagel, S.D., Zemanick, E.T., Kapsner, R., Penvari, C., etal. (2007) Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 104: 20529-20533.
28. Harrison, F. (2007) Microbial ecology of the cystic fibrosis lung. Microbiology 153: 917-923.
29. Hassett, D.J. (1996) Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacteriol 178: 7322-7325.
30. Head, N.E., and Yu, H. (2004) Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun 72: 133-144.
31. Hill, D., Rose, B., Pajkos, A., Robinson, M., Bye, P., Bell, S., etal. (2005) Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol 43: 5085-5090.
32. Hoboth, C., Hoffmann, R., Eichner, A., Henke, C., Schmoldt, S., Imhof, A., etal. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200: 118-130.
33. Hoffman, L.R., Deziel, E., D'Argenio, D.A., Lepine, F., Emerson, J., McNamara, S., etal. (2006) Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 103: 19890-19895.
34. Hoffman, L.R., Richardson, A.R., Houston, L.S., Kulasekara, H.D., Martens-Habbena, W., Klausen, M., etal. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
35. Høiby, N. (2006) P. aeruginosa in cystic fibrosis patients resists host defenses, antibiotics. Microbe 1: 571-577.
36. Høiby, N., and Frederiksen, B. (2000) Microbiology of cystic fibrosis. In Cystic Fibrosis. Hodson, M.E., and Geddes, D.M. (eds). London: Arnold, pp. 83-107.
37. Høiby, N., Frederiksen, B., and Pressler, T. (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 (Suppl. 2): 49-54.
38. Hu, Y.M., Butcher, P.D., Sole, K., Mitchison, D.A., and Coates, A.R. (1998) Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett 158: 139-145.
39. Jelsbak, L., Johansen, H.K., Frost, A.L., Thogersen, R., Thomsen, L.E., Ciofu, O., etal. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
40. Jesaitis, A.J., Franklin, M.J., Berglund, D., Sasaki, M., Lord, C.I., Bleazard, J.B., etal. (2003) Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 171: 4329-4339.
41. Jewes, L.A., and Spencer, R.C. (1990) The incidence of anaerobes in the sputum of patients with cystic fibrosis. J Med Microbiol 31: 271-274.
42. Jones, A.M., Govan, J.R., Doherty, C.J., Dodd, M.E., Isalska, B.J., Stanbridge, T.N., and Webb, A.K. (2001) Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358: 557-558.
43. Jung, A., Kleinau, I., Schonian, G., Bauernfeind, A., Chen, C., Griese, M., etal. (2002) Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J 20: 1457-1463.
44. Kerem, B., Rommens, J.M., Buchanan, J.A., Markiewicz, D., Cox, T.K., Chakravarti, A., etal. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080.
45. Kilbourn, J.P. (1978) Bacterial content and ionic composition of sputum in cystic fibrosis. Lancet 1: 334.
46. Klepac-Ceraj, V., Lemon, K.P., Martin, T.R., Allgaier, M., Kembel, S.W., Knapp, A.A., etal. (2010) Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 12: 1293-1303.
47. Kresse, A.U., Dinesh, S.D., Larbig, K., and Romling, U. (2003) Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol Microbiol 47: 145-158.
48. Kureishi, A., Diver, J.M., Beckthold, B., Schollaardt, T., and Bryan, L.E. (1994) Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother 38: 1944-1952.
49. Lam, J., Chan, R., Lam, K., and Costerton, J.W. (1980) Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28: 546-556.
50. Lee, B., Haagensen, J.A., Ciofu, O., Andersen, J.B., Hoiby, N., and Molin, S. (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 5247-5255.
51. Mahenthiralingam, E., Campbell, M.E., and Speert, D.P. (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596-605.
52. Mandsberg, L.F., Ciofu, O., Kirkby, N., Christiansen, L.E., Poulsen, H.E., and Hoiby, N. (2009) Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 53: 2483-2491.
53. Marshall, B.C., and Hazle, L. (2009) Cystic Fibrosis Foundation Patient Registry: Annual Data Report 2008. Bethesda, MD: Cystic Fibrosis Foundation.
54. Mathee, K., Ciofu, O., Sternberg, C., Lindum, P.W., Campbell, J.I., Jensen, P., etal. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145 (Part 6): 1349-1357.
55. Nelson, L.K., D'Amours, G.H., Sproule-Willoughby, K.M., Morck, D.W., and Ceri, H. (2009) Pseudomonas aeruginosa las and rhl quorum-sensing systems are important for infection and inflammation in a rat prostatitis model. Microbiology 155: 2612-2619.
56. Nguyen, D., and Singh, P.K. (2006) Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci USA 103: 8305-8306.
57. Ohman, D.E., and Chakrabarty, A.M. (1982) Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun 37: 662-669.
58. Oliver, A., Canton, R., Campo, P., Baquero, F., and Blazquez, J. (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251-1254.
59. Palmer, K.L., Aye, L.M., and Whiteley, M. (2007a) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087.
60. Palmer, K.L., Brown, S.A., and Whiteley, M. (2007b) Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol 189: 4449-4455.
61. Prunier, A.L., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J.F., and Leclercq, R. (2003) High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187: 1709-1716.
62. Rau, M.H., Hansen, S.K., Johansen, H.K., Thomsen, L.E., Workman, C.T., Nielsen, K.F., etal. (2010) Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 12: 1643-1658.
63. Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., etal. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
64. Rogers, G.B., Hoffman, L.R., Whiteley, M., Daniels, T.W., Carroll, M.P., and Bruce, K.D. (2010) Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol 18: 357-364.
65. Roman, F., Canton, R., Perez-Vazquez, M., Baquero, F., and Campos, J. (2004) Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol 42: 1450-1459.
66. Rommens, J.M., Iannuzzi, M.C., Kerem, B., Drumm, M.L., Melmer, G., Dean, M., etal. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
67. Sandoz, K.M., Mitzimberg, S.M., and Schuster, M. (2007) Social cheating in Pseudomonas aeruginosa quorum sensing. Proc Natl Acad Sci USA 104: 15876-15881.
68. Sibley, C.D., Parkins, M.D., Rabin, H.R., Duan, K., Norgaard, J.C., and Surette, M.G. (2008) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 105: 15070-15075.
69. Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J., and Greenberg, E.P. (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764.
70. Smith, E.E., Buckley, D.G., Wu, Z., Saenphimmachak, C., Hoffman, L.R., D'Argenio, D.A., etal. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103: 8487-8492.
71. Son, M.S., Matthews, W.J., Jr, Kang, Y., Nguyen, D.T., and Hoang, T.T. (2007) In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 75: 5313-5324.
72. Spoering, A.L., and Lewis, K. (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183: 6746-6751.
73. Terry, J.M., Pina, S.E., and Mattingly, S.J. (1991) Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1. Infect Immun 59: 471-477.
74. Vogne, C., Aires, J.R., Bailly, C., Hocquet, D., and Plesiat, P. (2004) Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 48: 1676-1680.
75. Whiteley, M., Bangera, M.G., Bumgarner, R.E., Parsek, M.R., Teitzel, G.M., Lory, S., and Greenberg, E.P. (2001) Gene expression in Pseudomonas aeruginosa biofilms. Nature 413: 860-864.
76. Wilder, C.N., Allada, G., and Schuster, M. (2009) Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 77: 5631-5639.
77. Williams, P., and Camara, M. (2009) Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 12: 182-191.
78. Wolfgang, M.C., Kulasekara, B.R., Liang, X., Boyd, D., Wu, K., Yang, Q., etal. (2003) Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100: 8484-8489.
79. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K.C., etal. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325.
80. Wu, H., Song, Z., Givskov, M., Doring, G., Worlitzsch, D., Mathee, K., etal. (2001) Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147: 1105-1113.
81. Wu, W., Badrane, H., Arora, S., Baker, H.V., and Jin, S. (2004) MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J Bacteriol 186: 7575-7585.
82. Yang, L., Haagensen, J.A., Jelsbak, L., Johansen, H.K., Sternberg, C., Hoiby, N., and Molin, S. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190: 2767-2776.